Skip to content
PICO Portalanswers from OpenAlex

Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease

PaperCitations, authors & open-access status

Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease is a paper indexed in PICO Portal from OpenAlex.

How many citations does Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease have?

PICO Portalcitation count

Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease has 1,062 citations in the OpenAlex counts PICO Portal stores.

When was Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease published?

PICO Portalyear

Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease has 2018 year in the PICO Portal index.

What is the open-access status of Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease?

PICO Portaloa status

Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease has bronze oa status in the PICO Portal index.

What is the DOI of Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease?

PICO Portaldoi

The DOI for Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease is on the source record.

What is the PMID of Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease?

PICO Portalpmid

The PMID for Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease is on the source record.

What is the OpenAlex record for Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease?

PICO Portalopenalex

The OpenAlex for Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial